Second wave of EU4Health calls 2024 - Health promotion and prevention of noncommunicable and communicable diseases, including: vaccine-preventable and other cancers caused by infections smoke- and aerosol-free environments
- Organization:
- European Commission
- Category:
- Projectes de recerca
- Scope:
- Start:
- Internal deadline:
- Official deadline:
- Amount:
- Discretionary
- Description:
-
Health promotion and prevention of noncommunicable and communicable diseases, including: vaccine-preventable and other cancers caused by infections smoke- and aerosol-free environments.
The expected results include:
a) identification and piloting of best and promising practices through population-level interventions; b) guidelines and evidence-based recommendations for prevention and control of communicable diseases;
c) awareness-raising campaigns and activities targeting vulnerable groups and communities;
d) training, upskilling and reskilling for health professionals in terms of prevention, monitoring and management of communicable diseases, focusing on vulnerable groups;
e) activities that provide support to patient groups and organisations representing vulnerable groups.
This action is expected to: Sub-topic (c): contribute to reducing the burden of specific communicable diseases in Member States.
Objective:
The aim of this action is to contribute to reducing the burden caused by NCDs and communicable diseases and their risk factors, supporting Member States' actions. The action targets:
Sub-topic (c): Communicable diseases (HIV/AIDS, Tuberculosis, viral hepatitis).
Sub-topic (c) is linked to and supports the activities under DP/CR-g-24-28 Direct grants to Member States' authorities: Cancers caused by infections, vaccine-preventable cancers and addressing communicable diseases (HIV/AIDS, Tuberculosis, Hepatitis).
Scope:
Sub-topic (c):
Activities will aim to:
a) support Member States and countries associated to the EU4Health Programme in their actions to prevent, monitor and manage communicable diseases, such as HIV/AIDS, Tuberculosis and viral hepatitis;
b) support Member States in their actions to address stigma and discrimination.
More specific activities will include:
a) development of best and promising practices, innovative policies, cost-effective approaches and research to prevent and monitor communicable diseases in the Union (HIV/AIDS, Tuberculosis, viral hepatitis);
b) awareness-raising to tackle stigma and discrimination;
c) targeted actions for vulnerable groups (e.g., drug users, migrants, people in prison)
d) capacity-building for health professionals, including in terms of communication skills, and support for patient groups and vulnerable groups.
Activities under sub-topic (c) should ideally complement the activities carried out under DP/CR-g-24-28 Direct grants to Member States' authorities: cancers caused by infections, vaccine-preventable cancers and addressing communicable diseases (HIV/AIDS, TB, HBV and HVC).
All activities under this call will cover the promotion of health and the prevention and management of NCDs and communicable diseases, supporting in particular vulnerable population groups, including displaced people from Ukraine (as beneficiaries of the access to healthcare provided by the Temporary Protection Directive, when they need special actions to be integrated in the regular national health systems) and Roma in the EU. Activities should also include an equity dimension and aim at reducing health inequalities.
- Requirements
-
Applicants must be legally established organisations, public authorities or public sector bodies (in particular, research and health institutions, universities and higher education establishments) in EU Member States (including overseas countries and territories linked to it (OCTs).
Applications will also be accepted from EEA countries and countries associated to the EU4Health Programme (third countries, candidate countries and potential candidate countries, neighbourhood countries) or countries which are in ongoing negotiations for an association agreement and where the agreement enters into force before grant signature.
- Request
-
In case of interest, please click on "m'interessa" and we will contact you.